Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/41677
Title: Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
Authors: 
Keywords: 
Mesh: 
Issue Date: Apr-2017
Citation: J. Allergy Clin. Immunol..2017 Apr;(139)4:1282-1292
Abstract: X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency with high morbidity and mortality compared with those seen in healthy subjects. Hematopoietic cell transplantation (HCT) has been considered a curative therapy, but the procedure has inherent complications and might not be available for all patients.
PMID: 27697500
URI: https://hdl.handle.net/20.500.12530/41677
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos

Files in This Item:
File Description SizeFormat 
PMC5374029.pdf719.86 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.